Expression of human sperm protein 17 in melanophages of cutaneous melanocytic lesions [8]

British Journal of Dermatology

Volumn 150, Issue 4, 2004, Pages 780-782

  Franceschini, B ^a,b   Grizzi, F ^a,b   Colombo, P ^a   Soda, G ^c   Bumm, K ^d   Hermonat, P L ^e   Monti, M ^a,f   Dioguardi, N ^a,b   Chiriva Internati, M ^g  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Fondazione Michele Rodriguez   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f UNIVERSITY OF MILAN   (Italy)

^g TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; HUMAN SPERM PROTEIN 17; PARAFFIN; UNCLASSIFIED DRUG;

BLUE NEVUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; LETTER; LINEAR REGRESSION ANALYSIS; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; NEVUS; NEVUS CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION;

ANTIGENS, SURFACE; AUTOANTIGENS; CARRIER PROTEINS; DYSPLASTIC NEVUS SYNDROME; HUMANS; MACROPHAGES; MELANOMA; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 2342620153     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0007-0963.2004.05887.x     Document Type: Letter

References (10)

1. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002: 146 (Suppl. 61): 1-6.
2. Houghton AN, Gold JS, Blachere NE. Immunity against cancer lessons learned from melanoma. Curr Opin Immunol 2001; 13: 134-10.
3. Scanlan MJ, Gure AO, Jungbluth AA et al. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002; 188: 22-32.
4. Juretic A, Spagnoli GC, Schultz-Thater E, Sarcevic B. Cancer/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies. Lancet Oncol 2003; 4: 104-9.
5. Lim SH, Wang Z, Chiriva-Internati M, Xue Y. Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma. Blood 2001; 97: 1508-10.
6. Chiriva-Internati M, Wang Z, Salati E et al. Tumor vaccine for ovarian carcinoma targeting sperm protein 17. Cancer 2002; 94: 2447-53.
7. Grizzi F, Lim SH, Chiriva-Internati M et al. Sperm protein 17 is not expressed on normal leukocytes. Blood 2002; 99: 3479-80.
8. Grizzi F, Chiriva-Internati M, Franceschini B et al. Immunolocalisation of sperm protein 17 in human testis and ejaculated spermatozoa. J Histochem Cytochem 2003; 51: 1245-8.
9. Chiriva-Internati M, Wang Z, Salati E et al. Sperm protein 17 (Sp 17) is a suitable target for immunotherapy of multiple myeloma. Blood 2002; 100: 961-5.
10. Chiriva-Internati M, Grizzi F, Franceschini B et al. Is sperm protein 17 a useful target for tumour immunotherapy? Blood 2003; 102: 2308-9.